The Mesothelioma Center News - Page 2
Dr. Mags Portman, HIV Prevention Pioneer, Dies from Mesothelioma at 44
- by Tim Povtak
- Celebrities
- Feb 14, 2019
Dr. Mags Portman, a British trailblazer in the fight to prevent and control HIV, died Wednesday after a two-year battle with mesothelioma. She was 44. Portman was lauded for…
Read More
J&J Talc Supplier Imerys Files for Bankruptcy Over Cancer Lawsuits
- by Tim Povtak
- Legislation & Litigation
- Feb 14, 2019
Seeking protection from rapidly mounting litigation, Imerys Talc America and two of its subsidiaries filed for Chapter 11 bankruptcy protection Wednesday in Delaware. Imerys is a major talc supplier for…
Read More
Chemo-Carrying Gold Nanoparticles Tested on Mesothelioma
- by Daniel King
- Research & Clinical Trials
- Feb 12, 2019
Italian researchers have found early success using gold nanoparticles as a chemotherapy-delivery vehicle for mesothelioma. They are hopeful their discovery will lead to an improvement in mesothelioma…
Read More
Mesothelioma Immunotherapy Combination Gaining Momentum
- by Tim Povtak
- Research & Clinical Trials
- Feb 11, 2019
Recent studies from France and the Netherlands have shown patients with pleural mesothelioma can benefit significantly from a second-line immunotherapy drug combination. In separate phase II studies, the combination of…
Read More
State Attorneys General Push for Tougher Asbestos Reporting Rule
- by Tim Povtak
- Legislation & Litigation
- Feb 6, 2019
A coalition of 15 attorneys general are calling for a tougher asbestos reporting rule as part of the recently-revised Toxic Substances Control Act. Maine’s newly elected Attorney General Aaron Frey…
Read More
Senator Probing Johnson & Johnson About Asbestos in Talc
- by Tim Povtak
- Legislation & Litigation
- Feb 4, 2019
Sen. Patty Murray, D-Wash., has questions, and she wants answers from Johnson & Johnson about its iconic baby powder and the reported link to asbestos-related cancers. Murray recently sent a…
Read More
Apatinib Case Study Uncovers Potential Mesothelioma Treatment
- by Tim Povtak
- Treatment & Doctors
- Jan 31, 2019
Doctors in China may have uncovered an effective second- or third-line treatment option for patients with malignant pleural mesothelioma. Dr. RongQin Meng, an oncologist at 363 Hospital in Cheng Du,…
Read More
Gene-Editing Tool Reverses Cancer Resistance to Chemotherapy
- by Suzanne Dixon
- Treatment & Doctors
- Jan 28, 2019
A team of researchers at the Gene Editing Institute in Newark, Delaware, has successfully treated chemotherapy-resistant lung cancer cells with the CRISPR gene-editing technique. The study was published Dec. 21,…
Read More
Vaccine and Chemotherapy Combo Shows Promise for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Jan 22, 2019
Mesothelioma patients showed an impressive immune response to TroVax, a novel cancer vaccine, when it was combined with standard chemotherapy in a recent clinical trial. Researchers from Cardiff University in…
Read More
Mesothelioma Researchers Seek More Effectiveness from Immunotherapy
- by Tim Povtak
- Treatment & Doctors
- Jan 17, 2019
Novel immunotherapy drugs may be working well for some patients with mesothelioma, but not enough to satisfy Dr. Raffit Hassan at the National Cancer Institute. It’s not even close…
Read More
